Conference Coverage (ASCO)
Rituximab/(alpha)Interferon Combination Immunotherapy Trial Completed
Published in Cancer Weekly, June 8th, 1998
Researchers from Stanford University Medical Center, California, the Fred Hutchinson Cancer Research Center, Washington, IDEC Pharmaceuticals Corp., California, the University of Virginia, and the University of Iowa, conducted a phase II clinical trial which combined the chimeric anti-CD20 monoclonal antibody, Rituximab, and (alpha)IFN in patients with CD20-positive LG/F NHL.
Results were presented at the 34th Annual Meeting of the American Society of Clinical Oncology, held May 16-19, 1998, in Los...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1998-06-08)
More Articles from Cancer Weekly
- Conference Coverage (ASCO)
Antibody Therapy Makes Waves in Clinical Trials - Conference Coverage (ASCO)
Allovectin-7 Cancer Gene Therapy Completes Phase II Studies - Conference Coverage (ASCO)
Poor Results Send Researchers Looking Elsewhere - Conference Coverage (ASCO)
Years Bring Experience to High Dose IL-2 Therapy for Cancer Patients - Cancer Vaccines
Vaccinated Mice Reject Established Tumors - Disease Course
Compensated HCV-Related Cirrhosis Has Poor Prognosis - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
